🇺🇸 FDA
Pipeline program

PACLITAXEL , BNT327, PEMETREXED , CARBOPLATIN , BNT327, PEMBROLIZUMAB

BNT327-06

Phase 3 small_molecule active

Quick answer

PACLITAXEL , BNT327, PEMETREXED , CARBOPLATIN , BNT327, PEMBROLIZUMAB for Non-small cell lung cancer is a Phase 3 program (small_molecule) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
BioNTech Manufacturing GmbH
Indication
Non-small cell lung cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials